Hamel Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.5M | Sell |
64,967
-584
| -0.9% | -$136K | 4.55% | 3 |
|
|
2026
Q1 | $16M | Sell |
65,551
-772
| -1% | -$180K | 4.57% | 3 |
|
|
2025
Q4 | $13.7M | Sell |
66,323
-303
| -0.5% | -$59.9K | 4.14% | 5 |
|
|
2025
Q3 | $12.4M | Sell |
66,626
-130
| -0.2% | -$22.3K | 3.8% | 6 |
|
|
2025
Q2 | $10.2M | Buy |
66,756
+37
| +0.1% | +$5.69K | 3.45% | 8 |
|
|
2025
Q1 | $11.1M | Sell |
66,719
-160
| -0.2% | -$25K | 3.76% | 5 |
|
|
2024
Q4 | $9.67M | Sell |
66,879
-305
| -0.5% | -$47.3K | 3.11% | 8 |
|
|
2024
Q3 | $10.9M | Sell |
67,184
-134
| -0.2% | -$21.4K | 3.33% | 7 |
|
|
2024
Q2 | $9.84M | Buy |
67,318
+160
| +0.2% | +$23.8K | 3.1% | 10 |
|
|
2024
Q1 | $10.6M | Buy |
67,158
+575
| +0.9% | +$91.5K | 3.41% | 8 |
|
|
2023
Q4 | $10.4M | Buy |
66,583
+400
| +0.6% | +$61.3K | 3.68% | 4 |
|
|
2023
Q3 | $10.3M | Sell |
66,183
-260
| -0.4% | -$42.9K | 3.76% | 4 |
|
|
2023
Q2 | $11M | Buy |
66,443
+385
| +0.6% | +$62.1K | 3.85% | 3 |
|
|
2023
Q1 | $10.2M | Sell |
66,058
-32
| -0% | -$5.17K | 3.55% | 5 |
|
|
2022
Q4 | $11.7M | Sell |
66,090
-315
| -0.5% | -$54.4K | 4.06% | 3 |
|
|
2022
Q3 | $10.8M | Buy |
66,405
+408
| +0.6% | +$69K | 4.29% | 2 |
|
|
2022
Q2 | $11.7M | Sell |
65,997
-1,598
| -2% | -$285K | 4.62% | 2 |
|
|
2022
Q1 | $12M | Sell |
67,595
-1,203
| -2% | -$205K | 4.26% | 3 |
|
|
2021
Q4 | $11.8M | Sell |
68,798
-657
| -0.9% | -$108K | 4.22% | 5 |
|
|
2021
Q3 | $11.2M | Sell |
69,455
-2,440
| -3% | -$416K | 4.38% | 3 |
|
|
2021
Q2 | $11.8M | Sell |
71,895
-812
| -1% | -$134K | 4.52% | 3 |
|
|
2021
Q1 | $11.9M | Sell |
72,707
-1,121
| -2% | -$181K | 4.61% | 2 |
|
|
2020
Q4 | $11.6M | Sell |
73,828
-370
| -0.5% | -$54.6K | 4.76% | 3 |
|
|
2020
Q3 | $11M | Sell |
74,198
-270
| -0.4% | -$40K | 4.9% | 4 |
|
|
2020
Q2 | $10.5M | Buy |
74,468
+701
| +1% | +$102K | 5.04% | 3 |
|
|
2020
Q1 | $9.67M | Buy |
73,767
+3,696
| +5% | +$524K | 5.11% | 2 |
|
|
2019
Q4 | $10.2M | Buy |
70,071
+470
| +0.7% | +$63.7K | 4.21% | 3 |
|
|
2019
Q3 | $9.01M | Sell |
69,601
-405
| -0.6% | -$53.4K | 3.85% | 4 |
|
|
2019
Q2 | $9.75M | Sell |
70,006
-215
| -0.3% | -$29.8K | 4.28% | 2 |
|
|
2019
Q1 | $9.82M | Buy |
70,221
+3,415
| +5% | +$457K | 4.41% | 1 |
|
|
2018
Q4 | $8.62M | Buy |
66,806
+340
| +0.5% | +$47.4K | 4.3% | 2 |
|
|
2018
Q3 | $9.18M | Buy |
66,466
+125
| +0.2% | +$16.6K | 3.98% | 2 |
|
|
2018
Q2 | $8.05M | Sell |
66,341
-375
| -0.6% | -$46.8K | 3.7% | 4 |
|
|
2018
Q1 | $8.55K | Sell |
66,716
-1,115
| -2% | -$151K | 0.57% | 4 |
|
|
2017
Q4 | $9.48M | Sell |
67,831
-714
| -1% | -$99.5K | 4.48% | 3 |
|
|
2017
Q3 | $8.91M | Sell |
68,545
-600
| -0.9% | -$79.5K | 4.34% | 2 |
|
|
2017
Q2 | $9.15M | Buy |
69,145
+377
| +0.5% | +$48.1K | 4.6% | 2 |
|
|
2017
Q1 | $8.56M | Buy |
68,768
+160
| +0.2% | +$19.1K | 4.36% | 2 |
|
|
2016
Q4 | $7.9M | Buy |
68,608
+170
| +0.2% | +$19.6K | 4.07% | 2 |
|
|
2016
Q3 | $8.08M | Sell |
68,438
-275
| -0.4% | -$33.4K | 4.28% | 2 |
|
|
2016
Q2 | $8.33M | Sell |
68,713
-25
| -0% | -$2.84K | 4.32% | 2 |
|
|
2016
Q1 | $7.44M | Sell |
68,738
-225
| -0.3% | -$23.3K | 3.95% | 2 |
|
|
2015
Q4 | $7.08M | Buy |
68,963
+3,802
| +6% | +$382K | 4.52% | 2 |
|
|
2015
Q3 | $6.08M | Buy |
65,161
+3,995
| +7% | +$386K | 4.33% | 1 |
|
|
2015
Q2 | $5.96M | Buy |
61,166
+6,515
| +12% | +$652K | 3.92% | 2 |
|
|
2015
Q1 | $5.5M | Sell |
54,651
-2,215
| -4% | -$225K | 3.63% | 3 |
|
|
2014
Q4 | $5.95M | Sell |
56,866
-620
| -1% | -$65.3K | 3.86% | 2 |
|
|
2014
Q3 | $6.13M | Sell |
57,486
-1,095
| -2% | -$114K | 4.08% | 1 |
|
|
2014
Q2 | $6.13M | Sell |
58,581
-285
| -0.5% | -$28.8K | 4.05% | 2 |
|
|
2014
Q1 | $5.78M | Sell |
58,866
-450
| -0.8% | -$41.7K | 4% | 2 |
|
|
2013
Q4 | $5.43M | Buy |
+59,316
| New | +$5.47M | 3.81% | 2 |
|
Other funds holding JNJ
AACR
Hamel Associates's JNJ Position: Q2 2026 in Review
Hamel Associates reduced its Johnson & Johnson (JNJ) stake by 0.89% in Q2 2026, selling an estimated $136K and leaving 64,967 shares worth $16.5M. The position accounts for 4.55% of the portfolio, ranked #3.
Hamel Associates first reported a position in JNJ in Q4 2013 and has held it in 51 quarters since. 2,379 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Hamel Associates held 64,967 shares of Johnson & Johnson worth $16.5M as of Q2 2026.
- Hamel Associates sold 584 Johnson & Johnson shares in Q2 2026, an estimated $136K.
- Johnson & Johnson made up 4.55% of Hamel Associates's portfolio in Q2 2026, its #3 holding.
- Hamel Associates first reported a position in Johnson & Johnson in Q4 2013 and has held it in 51 quarters since.
- 2,379 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Hamel Associates's 13F filing for Q2 2026, filed 27 Jul 2026.